Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes

NCT06847178 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Type 2 Diabetes

Interventions

DIETARY_SUPPLEMENT: Placebo twice daily in blinding
DRUG: Low-dose LC-Z300-01 twice daily in blinding
DRUG: High-dose LC-Z300-01 twice daily in blinding
DRUG: High-dose LCZ300-1 twice daily in open-label

Sponsor

Shanghai Changzheng Hospital